Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn F Pierce

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 25, 2025
Why is the uptake of gene therapy in hemophilia less than expected?Glenn F Pierce, Mark Skinner, Brian O'Mahony, et al.
Thrombosis Research|April 5, 2015
Evaluation of the toxicology, pharmacokinetics, and local tolerance of recombinant factor IX Fc fusion protein in animalsJennifer A Dumont, Kenneth S Loveday, David R Light, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 10, 2017
Evaluation of recombinant factor VIII Fc (Eloctate) activity by thromboelastometry in a multicenter phase 3 clinical trial and correlation with bleeding phenotypeFrank Driessler, Maricel G Miguelino, Glenn F Pierce, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 20, 2020
Management of COVID-19-associated coagulopathy in persons with haemophiliaSteven W Pipe, Radoslaw Kaczmarek, Alok Srivastava, et al.
Thrombosis Research|October 31, 2015
Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc fusion protein in animalsJennifer A Dumont, Kenneth S Loveday, David R Light, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2002
Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscleJohn Doukas, Kate Blease, Darren Craig, et al.
Thrombosis and Haemostasis|March 18, 2006
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP)Tongyao Liu, Ciaran D Scallan, George J Broze, et al.
The Annals of Thoracic Surgery|August 14, 2002
Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imagingKeith A Horvath, John Doukas, Chia-Yang J Lu, et al.
Blood Advances|December 2, 2022
Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?Kathleen P Pratt, Devi Gunasekera, Pooja Vir, et al.
Journal of Thrombosis and Haemostasis : JTH|June 23, 2023
Hemophilia gene therapy: first, do no harmLeonard A Valentino, Radoslaw Kaczmarek, Glenn F Pierce, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Research and Practice in Thrombosis and Haemostasis|July 25, 2025
Why is the uptake of gene therapy in hemophilia less than expected?Glenn F Pierce, Mark Skinner, Brian O'Mahony, et al.
Thrombosis Research|April 5, 2015
Evaluation of the toxicology, pharmacokinetics, and local tolerance of recombinant factor IX Fc fusion protein in animalsJennifer A Dumont, Kenneth S Loveday, David R Light, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 10, 2017
Evaluation of recombinant factor VIII Fc (Eloctate) activity by thromboelastometry in a multicenter phase 3 clinical trial and correlation with bleeding phenotypeFrank Driessler, Maricel G Miguelino, Glenn F Pierce, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 20, 2020
Management of COVID-19-associated coagulopathy in persons with haemophiliaSteven W Pipe, Radoslaw Kaczmarek, Alok Srivastava, et al.
Thrombosis Research|October 31, 2015
Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc fusion protein in animalsJennifer A Dumont, Kenneth S Loveday, David R Light, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2002
Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscleJohn Doukas, Kate Blease, Darren Craig, et al.
Thrombosis and Haemostasis|March 18, 2006
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP)Tongyao Liu, Ciaran D Scallan, George J Broze, et al.
The Annals of Thoracic Surgery|August 14, 2002
Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imagingKeith A Horvath, John Doukas, Chia-Yang J Lu, et al.
Blood Advances|December 2, 2022
Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?Kathleen P Pratt, Devi Gunasekera, Pooja Vir, et al.
Journal of Thrombosis and Haemostasis : JTH|June 23, 2023
Hemophilia gene therapy: first, do no harmLeonard A Valentino, Radoslaw Kaczmarek, Glenn F Pierce, et al.
Pageof 10